Related Experiment Video
Updated: Mar 26, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Differences in clinical findings, pathology, and outcomes between C3 glomerulonephritis and membranoproliferative
Yukihiko Kawasaki1, Syuto Kanno2, Atsushi Ono2
1Department of Pediatrics, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan. kyuki@fmu.ac.jp.
Insights
Pediatric complement component C3 glomerulonephritis (C3GN) shows a worse prognosis and treatment response compared to immune-complex-mediated membranoproliferative glomerulonephritis (IC-MPGN). Differentiating these conditions is crucial for patient management.
Area of Science:
- Nephrology
- Pediatric Nephrology
- Immunology
Background:
- Distinguishing between C3 glomerulonephritis (C3GN) and immune-complex-mediated membranoproliferative glomerulonephritis (IC-MPGN) in pediatric patients is clinically significant.
- Idiopathic MPGN encompasses both C3GN and IC-MPGN, necessitating clearer diagnostic criteria.
Purpose of the Study:
- To compare the clinical manifestations, clinicopathological findings, and prognosis of pediatric C3GN and IC-MPGN.
- To evaluate the utility of differentiating between C3GN and IC-MPGN for treatment and prognostic assessments.
Main Methods:
- Retrospective analysis of 37 pediatric patients diagnosed with "idiopathic MPGN".
- Patients were divided into two groups: 19 with IC-MPGN (Group 1) and 18 with C3GN (Group 2).
- Comparison of clinical data, renal biopsy findings, and long-term outcomes between the two groups.
Main Results:
- C3GN patients (Group 2) showed a higher incidence of urinary protein excretion, hematuria, low serum C3 levels, and more severe histological damage (mesangial proliferation, glomerular sclerosis, interstitial fibrosis) at follow-up biopsy.
- Fewer C3GN patients presented with macro-hematuria or low serum C4 levels initially compared to IC-MPGN patients.
- A greater proportion of C3GN patients experienced treatment non-response or progressed to end-stage renal disease.
Conclusions:
- Pediatric C3GN is associated with a poorer treatment response and prognosis than IC-MPGN.
- Classifying idiopathic MPGN into C3GN and IC-MPGN is valuable for guiding clinical treatment and predicting patient outcomes.
- Long-term monitoring of pediatric C3GN patients is essential.
Background:
To clarify the clinical manifestations of pediatric complement component C3 glomerulonephritis (C3GN), we retrospectively evaluated differences in the clinicopathological findings and prognosis between C3GN and immune-complex-mediated membranoproliferative glomerulonephritis (IC-MPGN).
Methods:
Thirty-seven patients diagnosed with "idiopathic MPGN" were enrolled in this retrospective study. The patients were divided into two groups, with Group 1 consisting of 19 patients diagnosed with IC-MPGN and Group 2 consisting of 18 patients diagnosed with C3GN. The clinical findings and the prognosis were investigated for both groups.
Results:
Thirteen patients in Group 2 were identified by mandatory annual school screening for urinary abnormalities. The incidence of macro-hematuria and the frequency of low serum C4 values were lower in Group 2 patients than in Group 1 patients. At the time of the second renal biopsy, urinary protein excretion, incidence of hematuria, frequency of low serum C3 values, and scores for mesangial proliferation, glomerular sclerosis, and interstitial fibrosis were higher in Group 2 patients than in Group 1 patients. At the most recent follow-up examination, the number of patients categorized as non-responding or with end-stage renal disease was higher in Group 2 patients than in Group 1 patients.
Conclusions:
Our results suggest that the treatment response and prognosis of patients with C3GN are worse than those of patients with IC-mediated MPGN. Therefore, in the clinical context regarding treatment options and prognosis, it may be useful to classify idiopathic MPGN as C3GN or IC-MPGN. In addition, long-term follow-up of C3GN is necessary.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
09:16Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
Related Concept Videos
Nephrotic Syndrome I : Introduction
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management